Quick Takeaways
- Chubb Ltd reports institutional holdings through Form 13F filings.
- Latest reported quarter: Q4 2022.
- Latest reported holdings value: $29,898,058.
- Info
- Portfolio
- Insider Trading
- Financials
- Holders
13F Filings History of Chubb Ltd
- Latest 13F report
- Q4 2022 - 03 Feb 2023
- Value $
- $29,898,058
- Signature - Title
- Annmarie Hagan - Chief Accounting Officer
- Location
- Zurich, Switzerland
- Summary
- This page shows a list of all the recent 13F filings made by Chubb Ltd. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Chubb Ltd reported 3 stock holdings with total value $29,898,058 as of Q4 2022. Top holdings included GRAB, NU, and PTCT.
Follow Filing Activity
Follow Chubb Ltd and return when a new 13F portfolio filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Holdings Value
What Changed
- Most recent filing was accepted on 03 Feb 2023, 12:09.
- Reported value moved from $26,996,000 to $29,898,058.
Why This Matters
- This gives a plain-language read of holdings direction before you open full quarter tables.
- Use the filing links below to verify the exact SEC source document.
Official SEC Source
Backed by Form 13F
Portfolio holdings and changes are grounded in SEC Form 13F filings.
See Original Filing| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2022 | 3 | $29,898,058 | $0 | $0 | $0 | GRAB, NU, PTCT | 13F-HR | 03 Feb 2023, 12:09 |
| Q3 2022 | 3 | $26,996,000 | $0 | $0 | $0 | GRAB, NU, PTCT | 13F-HR | 04 Nov 2022, 10:02 |
| Q2 2022 | 3 | $24,794,000 | $0 | -$285,000 | -$285,000 | GRAB, NU, PTCT | 13F-HR | 05 Aug 2022, 09:50 |
| Q1 2022 | 4 | $40,165,000 | +$17,655,000 | $0 | +$17,655,000 | GRAB, NU, PTCT, NEWT | 13F-HR | 06 May 2022, 08:23 |
| Q4 2021 | 2 | $45,560,000 | +$45,234,000 | $0 | +$45,234,000 | GRAB, PTCT | 13F-HR | 04 Feb 2022, 09:44 |
| Q3 2021 | 1 | $304,000 | $0 | -$27,885,000 | -$27,885,000 | PTCT | 13F-HR | 08 Nov 2021, 15:16 |
| Q2 2021 | 3 | $28,231,000 | +$238,000 | -$6,004,839 | -$5,766,839 | DCT, PTCT, NEWT | 13F-HR | 05 Aug 2021, 14:29 |
| Q1 2021 | 2 | $35,299,000 | $0 | -$74,456,878 | -$74,456,878 | DCT, PTCT | 13F-HR | 05 May 2021, 10:02 |
| Q4 2020 | 3 | $106,657,000 | +$102,004,850 | -$446,000 | +$101,558,850 | DCT, SNY, PTCT | 13F-HR | 05 Feb 2021, 16:36 |
| Q3 2020 | 3 | $5,116,000 | $0 | -$22,711,650 | -$22,711,650 | SNY, PHR, PTCT | 13F-HR | 30 Oct 2020, 13:41 |
| Q2 2020 | 4 | $28,147,000 | +$4,439,248 | $0 | +$4,439,248 | SNY, PHR, PTCT, NEWT | 13F-HR | 11 Aug 2020, 11:03 |
| Q1 2020 | 3 | $20,271,000 | +$3,410 | $0 | +$3,410 | SNY, PTCT, NEWT | 13F-HR | 30 Apr 2020, 09:33 |
| Q4 2019 | 3 | $23,375,000 | +$4,601 | $0 | +$4,601 | SNY, PTCT, NEWT | 13F-HR | 14 Feb 2020, 11:00 |
| Q3 2019 | 3 | $21,512,000 | +$3,500 | $0 | +$3,500 | SNY, NEWT, PTCT | 13F-HR | 06 Nov 2019, 11:58 |
| Q2 2019 | 3 | $20,230,000 | $0 | -$128,362,496 | -$128,362,496 | SNY, NEWT, PTCT | 13F-HR | 07 Aug 2019, 10:25 |
| Q1 2019 | 12 | $148,927,000 | +$10,635 | -$2,000 | +$8,635 | MRK, SNY, BP, PFE, GSK | 13F-HR | 30 Apr 2019, 11:40 |
| Q4 2018 | 13 | $137,925,000 | +$3,013 | -$742,000 | -$738,987 | MRK, SNY, PFE, TTE, GSK | 13F-HR | 08 Feb 2019, 10:07 |
| Q3 2018 | 14 | $150,842,000 | +$3,272 | -$95,878,881 | -$95,875,609 | MRK, SNY, TTE, BP, PFE | 13F-HR | 31 Oct 2018, 11:51 |
| Q2 2018 | 21 | $237,950,000 | +$1,422,263 | $0 | +$1,422,263 | MS, JPM, ADM, BP, MRK | 13F-HR | 27 Jul 2018, 10:17 |
| Q1 2018 | 20 | $229,965,000 | +$224,022 | $0 | +$224,022 | MS, JPM, ADM, SNY, AZN | 13F-HR | 01 May 2018, 14:25 |
| Q4 2017 | 19 | $229,757,000 | +$9,719 | -$934,000 | -$924,281 | MS, JPM, SNY, ADM, AZN | 13F-HR | 26 Jan 2018, 14:08 |
| Q3 2017 | 21 | $229,324,000 | $0 | -$12,087,450 | -$12,087,450 | MS, SNY, MRK, ADM, JPM | 13F-HR | 27 Oct 2017, 10:18 |
| Q2 2017 | 21 | $235,387,000 | +$28,742 | $0 | +$28,742 | MS, SNY, MRK, ADM, JPM | 13F-HR | 28 Jul 2017, 10:28 |
| Q1 2017 | 22 | $231,601,000 | +$137 | -$2,084,625 | -$2,084,488 | MS, ADM, SNY, MRK, JPM | 13F-HR | 04 May 2017, 08:30 |
| Q4 2016 | 25 | $227,792,000 | +$1,019,037 | -$77,474 | +$941,563 | MS, ADM, SNY, MRK, JPM | 13F-HR | 14 Feb 2017, 14:48 |
| Q3 2016 | 24 | $220,516,000 | +$1,807,958 | -$22,088,930 | -$20,280,972 | ADM, MRK, GSK, SNY, AZN | 13F-HR | 14 Nov 2016, 17:49 |
| Q2 2016 | 27 | $231,340,000 | +$2,753,157 | -$148,085,000 | -$145,331,843 | ADM, SNY, GSK, MRK, AZN | 13F-HR | 12 Aug 2016, 11:28 |
| Q1 2016 | 38 | $366,975,000 | $0 | $0 | $0 | SNY, BAC, C, AAL, ADM | 13F-HR | 13 May 2016, 10:35 |